Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

[HIV seroprevalence among drug users in Togo].

Ekouevi DK, Coffie PA, Salou M, Kariyiare BG, Dagnra AC, Tchounga B, Prince-Davi M, Becquet R, Pitche VP.

Sante Publique. 2013 Jul-Aug;25(4):491-8. French.

PMID:
24404731
2.

[HIV seroprevalence and associated factors among men who have sex with men in Togo].

Ekouevi DK, Dagnra CY, Goilibe KB, Tchounga B, Orne-Gliemann J, Salou M, Anato S, Prince-David M, Pitche VP.

Rev Epidemiol Sante Publique. 2014 Apr;62(2):127-34. doi: 10.1016/j.respe.2013.11.074. Epub 2014 Mar 6. French.

PMID:
24613465
3.

HIV seroprevalence among inmates in Togo.

Ekouevi DK, D'almeida S, Salou M, Kariyiare BG, Coffie PA, Dagnra AC, Tchounga B, Becquet R, Prince-David M, Pitche VP.

Med Mal Infect. 2013 Jul;43(7):279-85. doi: 10.1016/j.medmal.2013.06.002. Epub 2013 Jul 29.

PMID:
23906419
4.

A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design.

Jauffret-Roustide M, Le Strat Y, Couturier E, Thierry D, Rondy M, Quaglia M, Razafandratsima N, Emmanuelli J, Guibert G, Barin F, Desenclos JC.

BMC Infect Dis. 2009 Jul 16;9:113. doi: 10.1186/1471-2334-9-113.

5.

[Behaviors on drug-abuse and prevalence of sexually transmitted diseases among drug users in Tianjin, China, from 2011 to 2015].

Guo Y, Zhou N, Li J, Ning TL, Guo W.

Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Feb;37(2):202-5. doi: 10.3760/cma.j.issn.0254-6450.2016.02.010. Chinese.

PMID:
26917515
6.

Prevalence of HIV and risky sexual behaviors among rural drug users: does age matter?

Crosby RA, Oser CB, Leukefeld CG, Havens JR, Young A.

Ann Epidemiol. 2012 Nov;22(11):778-82. doi: 10.1016/j.annepidem.2012.07.006. Epub 2012 Aug 14.

7.

[Analysis of HIV/syphilis/HCV infection among drug users in 15 cities, China].

Zhang YH, Bao YG, Sun JP, Tan HZ.

Zhonghua Yu Fang Yi Xue Za Zhi. 2010 Nov;44(11):969-74. Chinese.

PMID:
21215121
8.

High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lomé, Togo.

Dagnra AY, Vidal N, Mensah A, Patassi A, Aho K, Salou M, Monleau M, Prince-David M, Singo A, Pitche P, Delaporte E, Peeters M.

J Int AIDS Soc. 2011 Jun 10;14:30. doi: 10.1186/1758-2652-14-30.

9.

Behavioural risk factors and HIV infection of injection drug users at detoxification clinics in Puerto Rico.

Robles RR, Colón HM, Díaz N, Cancel LI, MacGowan R, Cole GE, Allen DM.

Int J Epidemiol. 1994 Jun;23(3):595-601.

PMID:
7960388
10.

Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.

Santana Rodríguez OE, Malé Gil ML, HernándezSantana JF, Limiñana Cañal JM, Martín Sánchez AM.

Eur J Epidemiol. 1998 Sep;14(6):555-61.

PMID:
9794122
11.

Was the 1988 HIV epidemic among Bangkok's injecting drug users a common source outbreak?

Wright NH, Vanichseni S, Akarasewi P, Wasi C, Choopanya K.

AIDS. 1994 Apr;8(4):529-32.

PMID:
8011258
12.

A tale of two countries: HIV among core groups in Togo.

Sobéla F, Pépin J, Gbéléou S, Banla AK, Pitche VP, Adom W, Sodji D, Frost E, Deslandes S, Labbé AC.

J Acquir Immune Defic Syndr. 2009 Jun 1;51(2):216-23. doi: 10.1097/QAI.0b013e31819c170f.

PMID:
19339896
13.

Injecting drug use and HIV infection in southwest China.

Zheng X, Tian C, Choi KH, Zhang J, Cheng H, Yang X, Li D, Lin J, Qu S, Sun X, et al.

AIDS. 1994 Aug;8(8):1141-7.

PMID:
7986413
14.

Risk factors for HIV seropositivity in a sample of drug users in drug treatment in Ho Chi Minh City, Vietnam.

Tran SD, Williams AB, Truong HT, Do NH.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Mar 1;17(3):283-7.

PMID:
9495230
15.

HIV prevalence among injection drug users in rural Guangxi China.

Liu W, Chen J, Rodolph M, Beauchamp G, Mâsse B, Wang S, Li R, Ruan Y, Zhou F, Leung MK, Lai S, Shao Y, Jackson JB.

Addiction. 2006 Oct;101(10):1493-8. Erratum in: Addiction. 2007 May;102(5):841.

PMID:
16968351
16.

The changing pattern of human immunodeficiency virus type 1 infection in intravenous drug users. Results of a six-year seroprevalence study in Palermo, Italy.

Romano N, Vitale F, Alesi DR, Bonura F, La Licata R, Intonazzo V, Dardanoni G, Mammina C.

Am J Epidemiol. 1992 Jun 1;135(11):1189-96.

PMID:
1626537
17.

Peripheral facial paralysis (PFP) and HIV infection in Togo.

Balogou AK, Kpemissi E, Nack-Nack M, Anani T, Agboli K, Prince DM, Grunitzky EK.

Acta Neurol Scand. 1998 Sep;98(3):200-3.

PMID:
9786618
18.

[Skin disease and HIV infection among inmates in Lomé, Togo: a study of 194 prisoners].

Akakpo AS, Ekouevi DK, Toure AM, Saka B, Sogan A, d'Almeida S, Kombate K, Tchangai-Walla K, Pitche P.

Med Sante Trop. 2014 Jul-Sep;24(3):326-8. doi: 10.1684/mst.2013.0182. French.

19.

Correlates of HIV infection among young adult short-term injection drug users.

Doherty MC, Garfein RS, Monterroso E, Brown D, Vlahov D.

AIDS. 2000 Apr 14;14(6):717-26.

PMID:
10807195
20.

Infection with HIV-1 subtypes B and E in injecting drug users screened for enrollment into a prospective cohort in Bangkok, Thailand.

Kitayaporn D, Vanichseni S, Mastro TD, Raktham S, Vaniyapongs T, Des Jarlais DC, Wasi C, Young NL, Sujarita S, Heyward WL, Esparza J.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Nov 1;19(3):289-95.

PMID:
9803972

Supplemental Content

Support Center